Psyence Biomedical Ltd.’s Current Ratio at a glance
Psyence Biomedical Ltd. reports current ratio of 11.04 for Mar 2025. The prior period recorded 0.09 (Mar 2024). Year over year the metric moved +10.94 (+11,758.4%). The rolling three-period average stands at 3.74. Data last refreshed Nov 20, 2025, 7:10 PM.
Latest reading
11.04 · Mar 2025
YoY movement
+10.94 (+11,758.4%)
Rolling average
3.74
Current Current Ratio
11.04
+10.94
+11,758.4%
Rolling average
3.74
Latest Value
11.04
Mar 2025
YoY Change
+10.94
Absolute
YoY Change %
+11,758.4%
Rate of change
3-Period Avg
3.74
Smoothed
Narrative signal
Psyence Biomedical Ltd.’s current ratio stands at 11.04 for Mar 2025. Year-over-year, the metric shifted by +10.94, translating into a +11,758.4% rate of change versus the prior period.
Pair this momentum with product cadence, pricing power, and capital allocation moves to understand durability.
Blend with balance sheet, cash flow, and peer benchmarks from AlphaPilot’s broader dashboards to shape an investable thesis.
How current ratio shapes Psyence Biomedical Ltd.'s story
As of Mar 2025, Psyence Biomedical Ltd. reports current ratio of 11.04. Monitor liquidity coverage to understand a company’s ability to meet near-term obligations from working capital.
Reading the current ratio
Ratios above 1.0 indicate more current assets than liabilities. Very high ratios may signal idle capital.
Use with other liquidity metrics
Pair current ratio with quick ratio and cash flow to assess how liquid assets convert to cash.
Valuation Multiples
Compare how the market prices revenue, equity, and operating cash flow versus peers and history.
Profitability & Margins
Understand cost structure and capital efficiency trends across gross, operating, and net results.
Growth Momentum
Track whether top-line, earnings, and free cash flow growth are accelerating or cooling.
Balance Sheet Strength
Evaluate leverage, liquidity, and cash generation capacity that underpin resilience.
Shareholder Returns
Follow dividend sustainability and cash generation relative to market value.
Psyence Biomedical Ltd. (PBM) FAQs
Answers tailored to Psyence Biomedical Ltd.’s current ratio profile using the latest Financial Modeling Prep data.
What is Psyence Biomedical Ltd.'s current current ratio?
As of Mar 2025, Psyence Biomedical Ltd. reports current ratio of 11.04. This reading reflects the latest filings and price data for PBM.
How is Psyence Biomedical Ltd.'s current ratio trending year over year?
Year-over-year, the figure shifts by +10.94 (+11,758.4%). Pair this context with revenue growth and free cash flow signals to gauge momentum for PBM.
Why does current ratio matter for Psyence Biomedical Ltd.?
The current ratio compares current assets to current liabilities to assess short-term liquidity. For Psyence Biomedical Ltd., operating within Healthcare — Biotechnology, tracking this metric helps benchmark management's execution against close competitors.
Is Psyence Biomedical Ltd.'s current ratio above its recent average?
Psyence Biomedical Ltd.'s rolling three-period average sits at 3.74. Comparing the latest reading of 11.04 to that baseline highlights whether momentum is building or fading for PBM.
How frequently is Psyence Biomedical Ltd.'s current ratio refreshed?
Data for PBM was last refreshed on Nov 20, 2025, 7:10 PM and updates automatically every 24 hours, keeping your valuation inputs current.